Gaviscon® Extra Strength Chewable Foamtabs in delightful Orange Burst flavor are designed to provide fast and effective relief from heartburn, acid reflux, and GERD (Gastro-Esophageal Reflux Disease) symptoms. These chewable tablets work immediately, forming a protective foam barrier that helps to block acid reflux for hours, making them an excellent choice for both day and night-time relief.
One of the significant advantages of Gaviscon® Extra Strength is that it is free from aluminum, lactose, and gluten, catering to a variety of dietary needs. This product is doctor recommended and is safe for adults and adolescents aged 12 and over. For children aged 6-11, the dosage is also simple and effective.
| Product Details | Information |
| Flavor | Orange Burst |
| Count | 60 Tablets |
| Key Features | Day and night-time relief, blocks acid reflux, free from aluminum, lactose, gluten |
The recommended dosage for adults and adolescents is to chew 2-4 tablets up to a maximum of 12 tablets daily. For children aged 6-11, the recommendation is to chew 1-2 tablets, with a maximum of 6 tablets daily. It is essential that doses are separated by at least two hours, and the tablets should be taken after meals and/or at bedtime when symptoms occur or as directed by a healthcare professional. Please note that these tablets should not be swallowed whole.
The medicinal ingredients include 313mg of Alginic Acid, derived from brown seaweed, and 63mg of Magnesium Carbonate per tablet. Non-medicinal ingredients include Calcium Stearate, Orange Flavor, Sodium Bicarbonate, and Sugar. Gaviscon® Extra Strength is a trusted solution for those seeking immediate relief from the discomfort of heartburn and acid reflux.
Always consult with a healthcare provider for more detailed information about this product, including potential side effects and contraindications. Gaviscon® Extra Strength Chewable Foamtabs are the perfect companion for those who want to manage their symptoms effectively and enjoy life to the fullest.

Reviews
There are no reviews yet.